CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 124 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $298,000 | +308.2% | 162,990 | +499.7% | 0.00% | +300.0% |
| Q1 2022 | $73,000 | -84.3% | 27,180 | -74.7% | 0.00% | -80.0% |
| Q4 2021 | $465,000 | +143.5% | 107,365 | +186.4% | 0.01% | +66.7% |
| Q3 2021 | $191,000 | +15.1% | 37,492 | +43.0% | 0.00% | +50.0% |
| Q2 2021 | $166,000 | -39.2% | 26,224 | -37.2% | 0.00% | -33.3% |
| Q4 2020 | $273,000 | +40.0% | 41,728 | +42.1% | 0.00% | -25.0% |
| Q3 2020 | $195,000 | +42.3% | 29,363 | +78.3% | 0.00% | 0.0% |
| Q2 2020 | $137,000 | -51.4% | 16,470 | -51.4% | 0.00% | -20.0% |
| Q4 2019 | $282,000 | +28.8% | 33,879 | +14.3% | 0.01% | -37.5% |
| Q3 2019 | $219,000 | -6.0% | 29,634 | +43.0% | 0.01% | -11.1% |
| Q2 2019 | $233,000 | – | 20,730 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |